Galligan J J
Department of Pharmacology and Toxicology, Michigan State University, East Lansing 48824.
J Pharmacol Exp Ther. 1992 Jan;260(1):306-12.
Previous studies have shown that 5-hydroxytryptamine1A (5-HT1A) receptors are localized only to a subset of myenteric neurons in guinea pig ileum; the purpose of this study was to determine the possible functional significance of this differential receptor localization. Nerve-mediated contractions of the longitudinal muscle, myenteric plexus of guinea pig ileum were studied in vitro. Contractions were evoked by single transmural electrical stimuli (0.5-msec duration, at 0.1 Hz; cholinergic) or trains of stimuli (10 or 20 Hz for 1 sec; noncholinergic; scopolamine, 1 microM present). The 5-HT1A agonist, 8-hydroxy-2-(n-dipropylamino)tetralin (DPAT), reduced cholinergic contractions by no more than 14% in the concentration range of 0.001 to 0.3 microM. At high concentrations (1 to 100 microM), DPAT inhibited longitudinal muscle, myenteric plexus contractions; the EC50 was 6 microM. 5-Hydroxytryptamine (5-HT) and 5-carboxamidotryptamine (5-CT) reduced longitudinal muscle, myenteric plexus contractions by a maximum of 35% and 24% at 100 and 30 microM, respectively. Spiperone and 1-(2-methoxyphenyl)-4-[4-(2-phthalimidobutyl]piperazine (NAN-190), two 5-HT1A receptor antagonists, did not block DPAT-induced inhibition of cholinergic contractions. DPAT (3, 10 and 30 microM) shifted histamine concentration-response curves to the right in an apparently competitive manner; Schild analysis yielded a pA2 of 5.2. DPAT (3, 10, 30 and 100 microM) also shifted bethanechol concentration-response curves to the right in an apparently competitive manner; Schild analysis yielded a pA2 of 5.5. These data indicate that DPAT blocks histamine and muscarinic receptors on longitudinal muscle.(ABSTRACT TRUNCATED AT 250 WORDS)
先前的研究表明,5-羟色胺1A(5-HT1A)受体仅定位于豚鼠回肠肌间神经丛的一部分神经元;本研究的目的是确定这种受体定位差异可能具有的功能意义。对豚鼠回肠纵行肌和肌间神经丛的神经介导收缩进行了体外研究。收缩由单次跨壁电刺激(持续时间0.5毫秒,频率0.1赫兹;胆碱能)或刺激串(10或20赫兹,持续1秒;非胆碱能;存在1微摩尔东莨菪碱)诱发。5-HT1A激动剂8-羟基-2-(二丙基氨基)四氢萘(DPAT)在0.001至0.3微摩尔的浓度范围内使胆碱能收缩降低不超过14%。在高浓度(1至100微摩尔)时,DPAT抑制纵行肌、肌间神经丛收缩;半数有效浓度(EC50)为6微摩尔。5-羟色胺(5-HT)和5-羧酰胺色胺(5-CT)分别在100和30微摩尔时使纵行肌、肌间神经丛收缩最大降低35%和24%。两种5-HT1A受体拮抗剂螺哌隆和1-(2-甲氧基苯基)-4-[4-(2-邻苯二甲酰亚胺丁基)]哌嗪(NAN-190)并未阻断DPAT诱导的胆碱能收缩抑制作用。DPAT(3、10和30微摩尔)以明显竞争性方式使组胺浓度-反应曲线右移;希尔德分析得出的拮抗常数(pA2)为5.2。DPAT(3、10、30和100微摩尔)也以明显竞争性方式使氨甲酰甲胆碱浓度-反应曲线右移;希尔德分析得出的pA2为5.5。这些数据表明,DPAT阻断纵行肌上的组胺和毒蕈碱受体。(摘要截短于250字)